Cellectar Biosciences: A Pivotal Year for Regulatory Submissions and Pipeline Expansion
The year 2026 represents a critical period for Cellectar Biosciences as it advances its radiopharmaceutical pipeline toward key commercial and...
The year 2026 represents a critical period for Cellectar Biosciences as it advances its radiopharmaceutical pipeline toward key commercial and...
In a major strategic move, Blackstone has committed to leading one of Australia's largest private financing deals to date. The...
AT&T has taken two significant steps to enhance its competitive standing in the U.S. telecommunications market, closing a multi-billion dollar...
Construction is now underway on Vulcan Energy's flagship integrated geothermal and lithium production facility in Germany's Upper Rhine Valley. The...
Spruce Power, formerly known as XL Fleet, has completed its transformation, now concentrating exclusively on managing residential solar energy systems....
Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations and a broadening...
Conduent Inc. is navigating a critical period as it prepares to report annual results, with the severity of a recent...
Chemical manufacturer LSB Industries has issued a new round of equity-based compensation to its executive team, a move designed to...
Formerly known as Allscripts Healthcare, Veradigm Inc. is navigating a critical period of corporate realignment with a dual-focused approach that...
The Chinese fintech firm Yirendai is actively pursuing a strategic pivot, embedding advanced technologies like blockchain and artificial intelligence into...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com